The effect of 24 weeks of atorvastatin treatment in addition to the basic therapy was studied in 52 patients suffering from chronic myocarditis with heart failure (NYHA classes I-II with preserved ejection fraction). It is shown that the use of atorvastatin in a daily dose of 5-20 mg leads to reduced activity of immune inflammation and is accompanied by positive dynamics of clinical symptoms. Refs 10. Figs 2. Tables 2.